As our industry landscape for Real World Research has changed exponentially, our Real World Solutions team performed a short questionnaire at ISPOR EU (2017) to gather insight on basic understanding of value and the future of research in this space. The PRA Insights Report contains results and analysis.
THE INSIGHT SERIES: Why do prescribers participate? - Part III
While Phase II-III studies include small datasets, comprising several hundred to several thousand patients, they provide the data necessary for drug…
PRA in China
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.
PRA INSIGHTS REPORT 2018 ISPOR-North America Survey Results
A summary of survey results from ISPOR’s Annual North America meeting, where we gathered insights on important developments in the real world…